Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes
Cornelis, Marilyn C.
Dam, Rob van
Girman, Cynthia J.
Laurie, Cathy C.
Mirel, Daniel B.
Hunter, David J.
Rimm, Eric Bruce::0ab2926c8242f35e5a982e3cf59f4987::600
Hu, Frank B.
MetadataShow full item record
CitationQi, Lu, Marilyn C. Cornelis, Peter Kraft, Majken Jensen, Rob M. van Dam, Qi Sun, Cynthia J. Girman, et al. 2010. “Genetic Variants in ABO Blood Group Region, Plasma Soluble E-Selectin Levels and Risk of Type 2 Diabetes.” Human Molecular Genetics 19 (9): 1856–62. https://doi.org/10.1093/hmg/ddq057.
AbstractBlood soluble E-selectin (sE-selectin) levels have been related to various conditions such as type 2 diabetes. We performed a genome-wide association study among women of European ancestry from the Nurses' Health Study, and identified genome-wide significant associations between a cluster of markers at the ABO locus (9q34) and plasma sE-selectin concentration. The strongest association was with rs651007, which explained similar to 9.71% of the variation in sE-selectin concentrations. SNP rs651007 was also nominally associated with soluble intracellular cell adhesion molecule-1 (sICAM-1) (P = 0.026) and TNF-R2 levels (P = 0.018), independent of sE-selectin. In addition, the genetic-inferred ABO blood group genotypes were associated with sE-selectin concentrations (P = 3.55 x 10(-47)). Moreover, we found that the genetic-inferred blood group B was associated with a decreased risk (OR = 0.44, 0.27-0.70) of type 2 diabetes compared with blood group O, adjusting for sE-selectin, sICAM-1, TNF-R2 and other covariates. Our findings indicate that the genetic variants at ABO locus affect plasma sE-selectin levels and diabetes risk. The genetic associations with diabetes risk were independent of sE-selectin levels.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41263054
- SPH Scholarly Articles